| Document | Type | Published |
|---|---|---|
| Eculizumab for the treatment and prevention of antibody-mediated rejection in kidney transplantation | D&T reviews | May 2026 |
| Intravenous immunoglobulin for acute myocarditis in paediatrics | D&T reviews | March 2026 |
| Bortezimib for thrombotic thrombocytopenic purpura | D&T reviews | December 2025 |
| Anakinra for immuno-oncologic meningoencephalitis | D&T reviews | November 2025 |
| EBV cytotoxic T-cells for lymphoproliferative disease | D&T reviews | November 2025 |
| Daratumumab for steroid-sensitive nephrotic syndrome | D&T reviews | November 2025 |
| Baricitinib for haploinsufficiency of A20 | D&T reviews | November 2025 |
| Benralizumab combination therapy for severe asthma | D&T reviews | November 2025 |
| Naloxegol and naldemedine for post-operative ileus following radical cystectomy | D&T reviews | September 2025 |
| Intralesional rituximab for localised pemphigus | D&T reviews | September 2025 |
